Your browser doesn't support javascript.
loading
Discussion on the Focus of On-site Inspection of Clinical Trials of Lung Cancer 
Targeted Therapy and Immunotherapy Drugs / 中国肺癌杂志
Chinese Journal of Lung Cancer ; (12): 506-510, 2022.
Article en Zh | WPRIM | ID: wpr-939739
Biblioteca responsable: WPRO
ABSTRACT
As lung cancer targeted therapy and immunotherapy drugs are the current hot spot in the research and development area of new anti-tumor drugs, the amount of clinical trial in this area is increasing year by year. On the basis of combing the on-site inspections of drug registration clinical trials from 2019 to 2021, combined with the characteristics of lung cancer targeted therapy and immunotherapy drugs, this paper discusses the focus of on-site inspection of clinical trials of such drugs, and puts forward suggestions for the compliant implementation of lung cancer clinical trials.
.
Asunto(s)
Palabras clave
Texto completo: 1 Base de datos: WPRIM Asunto principal: Terapia Molecular Dirigida / Factores Inmunológicos / Inmunoterapia / Neoplasias Pulmonares / Antineoplásicos Límite: Humans Idioma: Zh Revista: Chinese Journal of Lung Cancer Año: 2022 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Asunto principal: Terapia Molecular Dirigida / Factores Inmunológicos / Inmunoterapia / Neoplasias Pulmonares / Antineoplásicos Límite: Humans Idioma: Zh Revista: Chinese Journal of Lung Cancer Año: 2022 Tipo del documento: Article